Globus Medical Stock Forecast

Stock Price Forecast

The 13 analysts with 12-month price forecasts for Globus Medical stock have an average target of 91.54, with a low estimate of 71 and a high estimate of 115. The average target predicts an increase of 10.78% from the current stock price of 82.63.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$71	$91.54	$92	$115
Change	-14.07%	+10.78%	+11.34%	+39.17%

Analyst Ratings

The average analyst rating for Globus Medical stock from 14 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jul '24	Aug '24	Sep '24	Oct '24	Nov '24	Dec '24
Strong Buy	5	5	5	5	6	6
Buy	3	4	4	4	4	5
Hold	4	3	3	3	3	2
Sell	0	0	0	0	1	1
Strong Sell	0	0	0	0	0	0
Total	12	12	12	12	14	14

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Richard Newitter Truist Securities	Truist Securities	Hold Maintains $85 → $90	Hold	Maintains	$85 → $90	+8.92%	Dec 18, 2024
Jason Wittes Roth MKM	Roth MKM	Strong Buy Maintains $100 → $115	Strong Buy	Maintains	$100 → $115	+39.17%	Dec 17, 2024
Ryan Zimmerman BTIG	BTIG	Strong Buy Maintains $87 → $91	Strong Buy	Maintains	$87 → $91	+10.13%	Dec 12, 2024
Vik Chopra Wells Fargo	Wells Fargo	Buy Maintains $88 → $95	Buy	Maintains	$88 → $95	+14.97%	Dec 11, 2024
William Plovanic Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains $85 → $92	Strong Buy	Maintains	$85 → $92	+11.34%	Dec 9, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

2.55B

from 1.57B

62.39%

from 1.57B

Revenue Next Year

2.72B

from 2.55B

6.71%

from 2.55B

EPS This Year

3.04

from 1.07

184.46%

from 1.07

EPS Next Year

3.48

from 3.04

14.42%

from 3.04

Fiscal Year	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	785.37M	789.04M	958.10M	1.02B	1.57B	2.55B	2.72B	2.91B
Revenue Growth	10.15%	0.47%	21.43%	6.76%	53.34%	62.39%	6.71%	6.88%
EPS	1.52	1.01	1.44	1.85	1.07	3.04	3.48	3.98
EPS Growth	-1.30%	-33.55%	42.57%	28.47%	-42.16%	184.46%	14.42%	14.36%
Forward PE	-	-	-	-	-	27.15	23.73	20.75
No. Analysts	-	-	-	-	-	18	18	15

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026
High	2.6B	2.8B	3.0B
Avg	2.5B	2.7B	2.9B
Low	2.4B	2.6B	2.7B

Revenue Growth

Revenue Growth	2024	2025	2026
High	67.4%	10.8%	11.4%
Avg	62.4%	6.7%	6.9%
Low	55.6%	1.6%	-0.2%

EPS Forecast

EPS	2024	2025	2026
High	3.34	3.78	4.28
Avg	3.04	3.48	3.98
Low	2.85	3.20	3.46

EPS Growth

EPS Growth	2024	2025	2026
High	212.1%	24.2%	22.8%
Avg	184.5%	14.4%	14.4%
Low	166.5%	5.3%	-0.7%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.